DEXTROSE IN LACTATED R

DEXTROSE IN LACTATED RINGER'S INJECTION
DEXTROSE IN LACTATED RINGER'S INJECTION, RX ONLY.
STERILE, NONPYROGENIC SOLUTION FOR FLUID AND ELECTROLYTE REPLENISHMENT
AND CALORIC SUPPLY IN A SINGLE DOSE CONTAINER FOR INTRAVENOUS
ADMINISTRATION.
.
LATEX-FREE
.
BAG/CONTAINER VOLUME: 1,000 MILLILITERS (ML)
.
EACH 100 ML CONTAINS
5 G DEXTROSE HYDROUS, USP;
600 MG SODIUM CHLORIDE, USP (NACL);
310 MG SODIUM LACTATE (C3H5NAO3);
30 MG OF POTASSIUM CHLORIDE, USP (KCL); AND
20 MG CALCIUM CHLORIDE, USP (CACL2 · 2H20)
.
UNIT OF ISSUE IS A PACKAGE CONTAINING 14 EACH
(SINGLE DOSE CONTAINERS).
.
STORE AT ROOM TEMPERATURE (25°C); BRIEF
EXPOSURE UP TO 40°C DOES NOT ADVERSELY AFFECT
THE PRODUCT.
.
AVOID EXCESSIVE HEAT.
.
SUBJECT TO DAMAGE BY FREEZING.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
SPE2DP-27-T-0094
SECTION B
BAXTER HEALTHCARE CORP IV 04687 P/N NDC00338-0125-04
BAXTER HEALTHCARE CORPORATION 1G026 P/N 2B2074X
BAXTER HEALTHCARE CORPORATION 1G026 P/N NDC00338-0125-04
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018691099 0001 PG 5.000
NSN/MATERIAL:6505001161064
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-00-116-1064 Quantity: 5 PG Purchase Request: 7018691099QTY: 5 Delivery: 5 days ADO